Delivery Order SPE2DB24D2212-SPE2DB25FHQEB
Award Date
7/7/25
Potential Completion Date
7/8/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,966.07. The contract is a firm fixed price delivery order, without a set-aside designation, and has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $8,391.53 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The $9,178.23 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 28, 2025. The contract has a completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,120.74 fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 3, 2025 and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $23,251.84, is a firm fixed-price delivery order with a completion date of May 22, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds a...
The federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,222.62 and is a Firm Fixed Price Delivery Order with a completion date of May 22, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 17, 2024, with a ceiling value of $8,723.60 and a completion date of December 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $64,666.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a performance period ending on March 28, 2025. It is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication, to the Defense Logistics Agency (DLA). The $54,094.26 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,766.37 and is a firm fixed-price delivery order with a completion date of May 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp holds a...